Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative Cyberknife in Potentially Resectable Pancreas Cancer
NCT02707315Phase 1Unknown
- Sponsor
- Cooper University Health Care
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in pancreatic adenocarcinoma (PDAC), sponsored by Cooper University Health Care. Primary endpoint: Percentage of subjects who successfully undergo pancreaticoduodenectomy at 2 months. Status: unknown.
02
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02707315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707315.